ANH-USA has filed three lawsuits against the FDA in recent weeks. In each case, we have been joined as plaintiffs by dietary supplement formulators Durk Pearson and Sandy Shaw and the Coalition to End FDA and FTC Censorship. We are being represented by the law firm of Emord & Associates.
Americans are demanding to know how the US Food and Drug Administration makes its decisions about the medicine they take and the food they consume.
Bayer Healthcare could face a lawsuit in the US over its claim that selenium may reduce the risk of prostate cancer. Bayer makes that claim on advertisements and labels for its One A Day Men’s multivitamin.
On May 1, the US Food and Drug Administration (FDA) issued a warning letter to consumers to stop using Hydroxycut. The line of products was pulled from the market after reports of liver damage and one death, though those reports have yet to be documented.
The FDA has established a Transparency Task Force, and has called for public comment. We certainly applaud this as a hopeful sign. Openness in government is imperative, and prompt disclosure to the public of government activity ensures legitimacy and accountability.
As we have reported in previous issues of Pulse of Health Freedom, bisphenol A (BPA), a chemical in the packaging or contents of many products, may cause long-term health effects, including cancers of the breast, brain and testicles; lowered sperm counts, early puberty and other reproductive system defects; diabetes; attention deficit disorder, asthma, and autism. […]
Sen. Mike Enzi (R-WY) announced that the Senate HELP Committee has approved President Obama’s nomination of Dr. Margaret A. Hamburg, a former New York City health commissioner, as the next commissioner of the Food and Drug Administration. The approval process now moves to the full Senate.
Two physicians once leaned over to me during a break in a live radio interview and whispered, “It’s the joke in medicine: Newer is not necessarily better, especially when it comes to drugs.” I was dumbfounded. New drugs had to be better, right?
On March 2, the Government Accountability Office (GAO) released a report on dietary supplements, calling for the US Food and Drug Administration (FDA) to monitor supplements more closely and require increased adverse event reporting.
The Project on Government Oversight, an independent watchdog group that exposes problems in government, has learned that the Food and Drug Administration (FDA) has quietly reduced their enforcement of federal quality regulations at laboratories that develop medical devices. The FDA’s inspections of “good laboratory practices” dropped dramatically in the past few years: from 33 in […]